Legend Biotech Corporation
LEGN
$35.35
-$0.285-0.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.15% | 53.18% | 65.84% | 31.65% | 46.43% |
| Total Depreciation and Amortization | 10.36% | 12.02% | 23.09% | 17.14% | 16.95% |
| Total Amortization of Deferred Charges | -45.44% | -51.40% | -72.57% | -66.57% | -63.67% |
| Total Other Non-Cash Items | 542.08% | -34.15% | -94.32% | -33.50% | -64.12% |
| Change in Net Operating Assets | -345.03% | -407.87% | 99.51% | 1,032.68% | 63.54% |
| Cash from Operations | -92.60% | -10.38% | 63.38% | 54.63% | 60.23% |
| Capital Expenditure | 19.17% | 55.28% | 29.77% | 27.90% | 0.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 139.82% | 36.80% | -841.06% | -26.77% | -1,410.87% |
| Cash from Investing | 137.20% | 38.08% | -1,016.67% | -22.57% | -1,993.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.14% | -9.14% | -7.00% | 49.18% | 25.02% |
| Issuance of Common Stock | 10.30% | -98.80% | -98.78% | -98.78% | -99.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.26% | -99.30% | -99.28% | -99.12% | -99.69% |
| Foreign Exchange rate Adjustments | 1,117.26% | -112.70% | -405.72% | 187.40% | 120.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.33% | -291.93% | -301.55% | -434.49% | -220.92% |